Authors

• Rachel Woody
• Jasmine Wong (ORCID: https://orcid.org/0000-0001-6440-0431)
• Jessica Gibbs (ORCID: https://orcid.org/0000-0003-1785-0899)
• Natsuko Onishi (ORCID: https://orcid.org/0000-0003-4495-9187)
• Jennifer M. Rosenbluth (ORCID: https://orcid.org/0000-0003-1314-6976)
• Nola M. Hylton (ORCID: https://orcid.org/0000-0002-6747-1662)
• Alexa Glencer (ORCID: https://orcid.org/0000-0002-3183-1056)
• Alexander D. Borowsky (ORCID: https://orcid.org/0000-0003-3117-9202)
• Laura J. Esserman (ORCID: https://orcid.org/0000-0001-9202-4568)
• Kirithiga Ramalingam (ORCID: https://orcid.org/0000-0002-1774-6891)
• Gillian L. Hirst (ORCID: https://orcid.org/0000-0002-4502-0035)
• Christopher J. Schwartz (ORCID: https://orcid.org/0000-0002-8086-8429)
• Michael J. Campbell (ORCID: https://orcid.org/0000-0002-3788-9240)
• Hidetoshi Mori

Institutions

• University of California, San Francisco (US)
• University of California, Davis (US)

Publication Details

Journal

JAMA Oncology

Published

2025-01-16

DOI

https://doi.org/10.1001/jamaoncol.2024.5927

Citations

14

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

14.64